NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Healthcare Plans · USD

Progyny, Inc. (PGNY) Stock Analysis

Progyny, Inc. (PGNY) is a Healthcare Plans stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

PGNY

$28.44

−$0.14 (−0.49%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PGNY with… →

PGNY Key Statistics

As of Oct 21, 2026
Trading
Open
$28.55
Previous Close
$28.58
Day's Range
28.26–28.74
52-Week Range
16.10–33.07
Volume
712.71K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.02
Valuation
Market Cap
$2.18B
P/E Ratio
30.91
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.30
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.66
EPS (ttm)Profit attributable to each share over the last twelve months.
0.92
Financials (FY)
Revenue (FY)
$1.29B+10.40%
Net Income (FY)
$58.52M+7.70%
Profit marginThe share of revenue left as profit after all costs and taxes.
6.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
76.73M
1-Year Return
+46.52%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
1.13M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PGNY closed at $28.44, +46.52% over 1 year.

Progyny, Inc. (PGNY) has a market capitalization of $2.18B.

In fiscal 2025, PGNY reported revenue of $1.29B.

PGNY Stock Return by Calendar Year

Progyny, Inc. (PGNY) return since Oct 2019: what $10,000 became

1 year
$10,000 $14,652
+46.52%
5 years
$10,000 $4,642
−53.58%
Since Oct 2019
$10,000 $17,842
+78.42%

If you had invested $10,000 in Progyny, Inc. (PGNY) at the close on October 25, 2019, the earliest close on record here, it would have been worth $17,842 at the close on October 21, 2026: +78.42% in total, +8.64% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+10.75%
2025+48.87%
2024−53.60%
2023+19.36%
2022−38.13%
2021+18.78%
2020+54.43%
2019 (partial year)+72.21%

As of October 21, 2026.

PGNY Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.29B$58.52M4.5%
2024$1.17B$54.34M4.7%
2023$1.09B$62.04M5.7%
2022$786.91M$30.36M3.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.29B$304.48M$85.28M$58.52M4.5%
2024$1.17B$253.36M$67.46M$54.34M4.7%
2023$1.09B$238.80M$62.18M$62.04M5.7%
2022$786.91M$167.33M$23.34M$30.36M3.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PGNY Valuation vs Healthcare Plans Median

Median of 11 stocks
MetricPGNYHealthcare Plans medianvs median
P/E30.9126.3817% above
P/S ratio1.660.384.4x the median
Profit margin6.00%1.18%4.8 pts above

Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Progyny, Inc. (PGNY) at $2.18B. The company sits in the Healthcare sector, in the Healthcare Plans industry. The company reports 835 employees.

The most recent close on file for PGNY is $28.44, dated October 21, 2026. That is −$0.14 (−0.49%) against the previous close. The 52-week range on file runs from $16.10 to $33.07. The latest close sits 76.65% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.29B. Against the prior fiscal year total of $1.17B, that is a change of +10.40%. The same year closed with net income of $58.52M. That is +7.70% against the prior fiscal year. Profit margin runs at 6%. That is 4.8 percentage points above the Healthcare Plans median of 1.18%. Earnings per share on a trailing basis come to 0.92.

Across the 4 fiscal years on file, revenue moves from $786.91M in 2022 to $1.29B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

PGNY trades at a trailing price-to-earnings ratio of 30.91. That is 17.19% above the Healthcare Plans median of 26.38. The forward P/E on file is 12.3. Measured against sales, the shares trade at 1.66 times revenue. On price-to-sales that is 4.4 times the Healthcare Plans median of 0.38. 11 Healthcare Plans companies report these metrics, and the medians quoted come from that group.

The reported beta is 1.02. Daily returns over the trailing 7 years annualize to a volatility of 60.66%. The trailing one-year total return is +46.52%. Across 5 years the annualized return works out at −14.23%.

Growth & Income

No dividend is on file for PGNY.

2026 is still running; the total return is +10.75% year to date. Across the complete calendar years on file, 2020 returned +54.43% and 2024 returned −53.60%. Of the 6 complete calendar years on file, 4 finished higher.

Peer Comparison

Progyny, Inc. (PGNY) operates in the Healthcare Plans industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Progyny, Inc. PGNY $2.18B 30.9
UnitedHealth Group Incorporated UNH $374.30B 26.8
CVS Health Corporation CVS $119.52B 24.6
Elevance Health, Inc. ELV $94.15B 19.2

The Healthcare Plans industry average P/E ratio is 26.4x. Progyny, Inc. trades at a P/E of 30.9.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Healthcare Plans Stocks

UNH

UnitedHealth Group Incorporated

$374.30B

 CVS

CVS Health Corporation

$119.52B

 ELV

Elevance Health, Inc.

$94.15B

 CI

The Cigna Group

$79.88B

 HUM

Humana Inc.

$51.08B

 CNC

Centene Corporation

$34.16B
View all Healthcare Plans stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 MRK

Merck & Co., Inc.

$369.78B

 NVS

Novartis AG

$292.58B
View all Healthcare stocks →

About Progyny, Inc.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Visit website →